EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING BEVACIZUMAB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION

被引：0
|
作者：
Fujii, Mitsuhiro [1 ]
Iwakami, Shin-Ichiro [1 ]
Ihara, Hiroaki [1 ]
Hara, Munechika [1 ]
Iwakami, Naoko [1 ]
Ishiwata, Toshiji [1 ]
Takahashi, Kazuhisa [2 ]
机构：
[1] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [21] Retrospective study of chemotherapy for non-small cell lung cancer, complicated pleural effusion
    Ueda, Yasuto
    Yanai, Masaaki
    Izumi, Hiroki
    Sakamoto, Tomohiro
    Kinoshita, Naoki
    Takeda, Kenichi
    Makino, Haruhiko
    Kodani, Masahiro
    Igishi, Tadashi
    Shimizu, Eiji
    ANNALS OF ONCOLOGY, 2015, 26 : 124 - 124
  • [22] Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancer
    Shibaki, Ryota
    Murakami, Shuji
    Shinno, Yuki
    Matsumoto, Yuji
    Goto, Yasushi
    Kanda, Shintaro
    Horinouchi, Hidehito
    Fujiwara, Yutaka
    Motoi, Noriko
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (04) : 815 - 822
  • [23] Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis
    Hu, Yongqi
    Zhou, Zhenke
    Luo, Miao
    MEDICINE, 2022, 101 (52) : E32207
  • [24] Pleural effusion and pulmonary injury as an unusual complication to chemotherapy in non-small cell lung cancer patients
    Stathopoulos, GP
    Dourakis, SP
    Perdicaris, G
    Promponas, IE
    ONCOLOGY REPORTS, 2000, 7 (06) : 1311 - 1315
  • [25] Prognostic value of pleural effusion in patients with non-small cell lung cancer
    Sugiura, S
    Ando, Y
    Minami, H
    Ando, M
    Sakai, S
    Shimokata, K
    CLINICAL CANCER RESEARCH, 1997, 3 (01) : 47 - 50
  • [26] Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Yamadori, Tadahiro
    Nakao, Keiko
    Asami, Kazuhiro
    Yasue, Tomomi
    Otsuka, Tomoyuki
    Shiroyama, Takayuki
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Atagi, Shinji
    Kawase, Ichiro
    Hirashima, Tomonori
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [27] The Efficacy of Pleurodesis on Non-Small-Cell Lung Cancer with Large Malignant Pleural Effusion
    Kimura, Madoka
    Naito, Tateaki
    Kenmotsu, Hirokazu
    Nakamura, Yukiko
    Tsuya, Asuka
    Kaira, Kyoichi
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S402 - S402
  • [28] Development a predictive nomogram for spontaneous pleurodesis in patients with non-small cell lung cancer and malignant pleural effusion
    Tan, Sihan
    Zeng, Hao
    Huang, Qin
    Pu, Xin
    Li, Weimin
    Ali, Jason M.
    Nayak, Rahul
    Bhagat, Milind
    Li, Yalun
    Tian, Panwen
    JOURNAL OF THORACIC DISEASE, 2025, 17 (02)
  • [29] Molecular profile of malignant pleural effusion (MPE) in non-small cell lung cancer (NSCLC)
    Rodriguez, Irene Lojo
    Rial, Maribel Botana
    Montaos, Almudena Gonzalez
    Pineiro, Ana Gonzalez
    Hernandez, Cristina Ramos
    Delgado, Mercedes Cuna
    Delgado, Manuel Nunez
    Villar, Alberto Fernandez
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [30] EGFR mutations in malignant pleural effusion of non-small cell lung cancer:: A case report
    Huang, MJ
    Lim, KH
    Tzen, CY
    Hsu, HS
    Yen, Y
    Huang, BS
    LUNG CANCER, 2005, 49 (03) : 413 - 415
12345